comparemela.com

Dylan Brill News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Preliminary results of clinical trials show RSV vaccine protects newborns from severe illness

According to Pfizer, the vaccine showed 82% efficacy in preventing severe sickness during the most vulnerable first 90 days of a baby's life and 69% efficacy through the first six months.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.